APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gabapentin Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gabapentin Drug Industry Growth and Trends Forecast to 2032

20 December 2025125 pages

Choose your research edition.

Industry ResearchGabapentin Drug Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabapentin Drug Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Gabapentin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabapentin Drug Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabapentin Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Gabapentin Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gabapentin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gabapentin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gabapentin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gabapentin Drug include Teva, Sun Pharmaceutical, Mylan, Pfizer, Zydus Pharmaceuticals, Tris Pharma, Taro, Sciegen Pharmaceuticals and Marksans Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gabapentin Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gabapentin Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gabapentin Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gabapentin Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gabapentin Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gabapentin Drug Market by Company

Teva

Sun Pharmaceutical

Mylan

Pfizer

Zydus Pharmaceuticals

Tris Pharma

Taro

Sciegen Pharmaceuticals

Marksans Pharma

Lupin Limited

Jiangsu Hengrui Medicine

InvaGen Pharmaceuticals

Hi-Tech Pharmaceuticals

Glenmark

Epic Pharma

Depomed

CSPC Ouyi Pharmaceutical

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

ACI HealthCare Limited

Acella Pharmaceuticals

Gabapentin Drug Segment by Type

Capsule

Oral Solution

Tablet

Gabapentin Drug Segment by Application

Postherpetic Neuralgia in Adults

Partial Onset Seizures

Others

Gabapentin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabapentin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabapentin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabapentin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gabapentin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gabapentin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Oral Solution Table 3. Major Company of Tablet Table 4. Global Gabapentin Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 6. Global Gabapentin Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Gabapentin Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Gabapentin Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Gabapentin Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 11. Global Gabapentin Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Gabapentin Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Gabapentin Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Gabapentin Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 16. North America Gabapentin Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 18. Europe Gabapentin Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Gabapentin Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 22. Latin America Gabapentin Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Gabapentin Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Gabapentin Drug Industry Trends Table 26. Gabapentin Drug Industry Drivers Table 27. Gabapentin Drug Industry Opportunities and Challenges Table 28. Gabapentin Drug Industry Restraints Table 29. Global Gabapentin Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Gabapentin Drug Revenue Market Share by Company (2021-2026) Table 31. Global Gabapentin Drug Sales by Company (2021-2026) & (W Units) Table 32. Global Gabapentin Drug Sales Share by Company (2021-2026) Table 33. Global Gabapentin Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Gabapentin Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Gabapentin Drug Major Company Production Sites and Headquarters Table 36. Global Gabapentin Drug Company, Product Type & Application Table 37. Global Gabapentin Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Gabapentin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Gabapentin Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Gabapentin Drug Sales by Region (2021-2026) & (W Units) Table 42. Global Gabapentin Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Gabapentin Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Gabapentin Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Gabapentin Drug Sales by Region (2027-2032) & (W Units) Table 47. Global Gabapentin Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Gabapentin Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Gabapentin Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Gabapentin Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 53. Global Gabapentin Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Gabapentin Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Gabapentin Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Gabapentin Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 58. Global Gabapentin Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Gabapentin Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Gabapentin Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Gabapentin Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 63. North America Gabapentin Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 65. Europe Gabapentin Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Gabapentin Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 69. Latin America Gabapentin Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Gabapentin Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Gabapentin Drug Product Portfolio Table 76. Teva Recent Development Table 77. Sun Pharmaceutical Company Information Table 78. Sun Pharmaceutical Business Overview Table 79. Sun Pharmaceutical Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sun Pharmaceutical Gabapentin Drug Product Portfolio Table 81. Sun Pharmaceutical Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan Gabapentin Drug Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Gabapentin Drug Product Portfolio Table 91. Pfizer Recent Development Table 92. Zydus Pharmaceuticals Company Information Table 93. Zydus Pharmaceuticals Business Overview Table 94. Zydus Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Zydus Pharmaceuticals Gabapentin Drug Product Portfolio Table 96. Zydus Pharmaceuticals Recent Development Table 97. Tris Pharma Company Information Table 98. Tris Pharma Business Overview Table 99. Tris Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Tris Pharma Gabapentin Drug Product Portfolio Table 101. Tris Pharma Recent Development Table 102. Taro Company Information Table 103. Taro Business Overview Table 104. Taro Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Taro Gabapentin Drug Product Portfolio Table 106. Taro Recent Development Table 107. Sciegen Pharmaceuticals Company Information Table 108. Sciegen Pharmaceuticals Business Overview Table 109. Sciegen Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio Table 111. Sciegen Pharmaceuticals Recent Development Table 112. Marksans Pharma Company Information Table 113. Marksans Pharma Business Overview Table 114. Marksans Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Marksans Pharma Gabapentin Drug Product Portfolio Table 116. Marksans Pharma Recent Development Table 117. Lupin Limited Company Information Table 118. Lupin Limited Business Overview Table 119. Lupin Limited Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Lupin Limited Gabapentin Drug Product Portfolio Table 121. Lupin Limited Recent Development Table 122. Jiangsu Hengrui Medicine Company Information Table 123. Jiangsu Hengrui Medicine Business Overview Table 124. Jiangsu Hengrui Medicine Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio Table 126. Jiangsu Hengrui Medicine Recent Development Table 127. InvaGen Pharmaceuticals Company Information Table 128. InvaGen Pharmaceuticals Business Overview Table 129. InvaGen Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio Table 131. InvaGen Pharmaceuticals Recent Development Table 132. Hi-Tech Pharmaceuticals Company Information Table 133. Hi-Tech Pharmaceuticals Business Overview Table 134. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio Table 136. Hi-Tech Pharmaceuticals Recent Development Table 137. Glenmark Company Information Table 138. Glenmark Business Overview Table 139. Glenmark Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Glenmark Gabapentin Drug Product Portfolio Table 141. Glenmark Recent Development Table 142. Epic Pharma Company Information Table 143. Epic Pharma Business Overview Table 144. Epic Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Epic Pharma Gabapentin Drug Product Portfolio Table 146. Epic Pharma Recent Development Table 147. Depomed Company Information Table 148. Depomed Business Overview Table 149. Depomed Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Depomed Gabapentin Drug Product Portfolio Table 151. Depomed Recent Development Table 152. CSPC Ouyi Pharmaceutical Company Information Table 153. CSPC Ouyi Pharmaceutical Business Overview Table 154. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio Table 156. CSPC Ouyi Pharmaceutical Recent Development Table 157. Aurobindo Pharma Company Information Table 158. Aurobindo Pharma Business Overview Table 159. Aurobindo Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Aurobindo Pharma Gabapentin Drug Product Portfolio Table 161. Aurobindo Pharma Recent Development Table 162. Apotex Company Information Table 163. Apotex Business Overview Table 164. Apotex Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Apotex Gabapentin Drug Product Portfolio Table 166. Apotex Recent Development Table 167. Amneal Pharmaceuticals Company Information Table 168. Amneal Pharmaceuticals Business Overview Table 169. Amneal Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Amneal Pharmaceuticals Gabapentin Drug Product Portfolio Table 171. Amneal Pharmaceuticals Recent Development Table 172. Alkem Laboratories Company Information Table 173. Alkem Laboratories Business Overview Table 174. Alkem Laboratories Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Alkem Laboratories Gabapentin Drug Product Portfolio Table 176. Alkem Laboratories Recent Development Table 177. ACI HealthCare Limited Company Information Table 178. ACI HealthCare Limited Business Overview Table 179. ACI HealthCare Limited Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. ACI HealthCare Limited Gabapentin Drug Product Portfolio Table 181. ACI HealthCare Limited Recent Development Table 182. Acella Pharmaceuticals Company Information Table 183. Acella Pharmaceuticals Business Overview Table 184. Acella Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Acella Pharmaceuticals Gabapentin Drug Product Portfolio Table 186. Acella Pharmaceuticals Recent Development Table 187. North America Gabapentin Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 188. North America Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 189. North America Gabapentin Drug Sales Market Share by Country (2021-2026) Table 190. North America Gabapentin Drug Sales Forecast by Country (2027-2032) & (W Units) Table 191. North America Gabapentin Drug Sales Market Share Forecast by Country (2027-2032) Table 192. North America Gabapentin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. North America Gabapentin Drug Market Size by Country (2021-2026) & (US$ Million) Table 194. North America Gabapentin Drug Market Share by Country (2021-2026) Table 195. North America Gabapentin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. North America Gabapentin Drug Market Share Forecast by Country (2027-2032) Table 197. Europe Gabapentin Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 198. Europe Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 199. Europe Gabapentin Drug Sales Market Share by Country (2021-2026) Table 200. Europe Gabapentin Drug Sales Forecast by Country (2027-2032) & (W Units) Table 201. Europe Gabapentin Drug Sales Market Share Forecast by Country (2027-2032) Table 202. Europe Gabapentin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Europe Gabapentin Drug Market Size by Country (2021-2026) & (US$ Million) Table 204. Europe Gabapentin Drug Market Share by Country (2021-2026) Table 205. Europe Gabapentin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Europe Gabapentin Drug Market Share Forecast by Country (2027-2032) Table 207. Asia-Pacific Gabapentin Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 208. Asia-Pacific Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 209. Asia-Pacific Gabapentin Drug Sales Market Share by Country (2021-2026) Table 210. Asia-Pacific Gabapentin Drug Sales Forecast by Country (2027-2032) & (W Units) Table 211. Asia-Pacific Gabapentin Drug Sales Market Share Forecast by Country (2027-2032) Table 212. Asia-Pacific Gabapentin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Asia-Pacific Gabapentin Drug Market Size by Country (2021-2026) & (US$ Million) Table 214. Asia-Pacific Gabapentin Drug Market Share by Country (2021-2026) Table 215. Asia-Pacific Gabapentin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Asia-Pacific Gabapentin Drug Market Share Forecast by Country (2027-2032) Table 217. Latin America Gabapentin Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 218. Latin America Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 219. Latin America Gabapentin Drug Sales Market Share by Country (2021-2026) Table 220. Latin America Gabapentin Drug Sales Forecast by Country (2027-2032) & (W Units) Table 221. Latin America Gabapentin Drug Sales Market Share Forecast by Country (2027-2032) Table 222. Latin America Gabapentin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Latin America Gabapentin Drug Market Size by Country (2021-2026) & (US$ Million) Table 224. Latin America Gabapentin Drug Market Share by Country (2021-2026) Table 225. Latin America Gabapentin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Latin America Gabapentin Drug Market Share Forecast by Country (2027-2032) Table 227. Middle East and Africa Gabapentin Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 228. Middle East and Africa Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 229. Middle East and Africa Gabapentin Drug Sales Market Share by Country (2021-2026) Table 230. Middle East and Africa Gabapentin Drug Sales Forecast by Country (2027-2032) & (W Units) Table 231. Middle East and Africa Gabapentin Drug Sales Market Share Forecast by Country (2027-2032) Table 232. Middle East and Africa Gabapentin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Middle East and Africa Gabapentin Drug Market Size by Country (2021-2026) & (US$ Million) Table 234. Middle East and Africa Gabapentin Drug Market Share by Country (2021-2026) Table 235. Middle East and Africa Gabapentin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Middle East and Africa Gabapentin Drug Market Share Forecast by Country (2027-2032) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Gabapentin Drug Distributors List Table 240. Gabapentin Drug Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Gabapentin Drug Image Figure 2. Global Gabapentin Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gabapentin Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Gabapentin Drug Sales (2021-2032) & (W Units) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (W Units) Figure 7. Oral Solution Image Figure 8. Global Oral Solution Sales YoY Growth (2021-2032) & (W Units) Figure 9. Tablet Image Figure 10. Global Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Gabapentin Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Gabapentin Drug Market Share by Type 2025 VS 2032 Figure 13. North America Gabapentin Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Gabapentin Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Gabapentin Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Gabapentin Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Gabapentin Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Gabapentin Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Gabapentin Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Gabapentin Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Gabapentin Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Gabapentin Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Gabapentin Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Postherpetic Neuralgia in Adults Image Figure 26. Global Postherpetic Neuralgia in Adults Sales YoY Growth (2021-2032) & (W Units) Figure 27. Partial Onset Seizures Image Figure 28. Global Partial Onset Seizures Sales YoY Growth (2021-2032) & (W Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Gabapentin Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Gabapentin Drug Market Share by Application 2025 VS 2032 Figure 33. North America Gabapentin Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Gabapentin Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Gabapentin Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Gabapentin Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Gabapentin Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Gabapentin Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Gabapentin Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Gabapentin Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Gabapentin Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Gabapentin Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Gabapentin Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Gabapentin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Gabapentin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gabapentin Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Gabapentin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Gabapentin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gabapentin Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Gabapentin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Gabapentin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gabapentin Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Gabapentin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Gabapentin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gabapentin Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Gabapentin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Gabapentin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Gabapentin Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Gabapentin Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Postherpetic Neuralgia in Adults
  • Partial Onset Seizures
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • Pfizer
  • Zydus Pharmaceuticals
  • Tris Pharma
  • Taro
  • Sciegen Pharmaceuticals
  • Marksans Pharma
  • Lupin Limited
  • Jiangsu Hengrui Medicine
  • InvaGen Pharmaceuticals
  • Hi-Tech Pharmaceuticals
  • Glenmark
  • Epic Pharma
  • Depomed
  • CSPC Ouyi Pharmaceutical
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories
  • ACI HealthCare Limited
  • Acella Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gabapentin Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gabapentin Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gabapentin Drug Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Oral Solution
  8. 1.3.3 Tablet
  9. 1.4 Global Gabapentin Drug Market Size by Type
  10. 1.4.1 Global Gabapentin Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Gabapentin Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Gabapentin Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Gabapentin Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Gabapentin Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Gabapentin Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Gabapentin Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Gabapentin Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gabapentin Drug Industry Trends
  2. 2.2 Gabapentin Drug Industry Drivers
  3. 2.3 Gabapentin Drug Industry Opportunities and Challenges
  4. 2.4 Gabapentin Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gabapentin Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Gabapentin Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Gabapentin Drug Price (2021-2026)
  4. 3.4 Global Gabapentin Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gabapentin Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Gabapentin Drug Company, Product Type & Application
  7. 3.7 Global Gabapentin Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gabapentin Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gabapentin Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gabapentin Drug Tier 1, Tier 2, and Tier 3
4 Gabapentin Drug Regional Status and Outlook
  1. 4.1 Global Gabapentin Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gabapentin Drug Historic Market Size by Region
  3. 4.2.1 Global Gabapentin Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gabapentin Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gabapentin Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gabapentin Drug Forecasted Market Size by Region
  7. 4.3.1 Global Gabapentin Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gabapentin Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gabapentin Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gabapentin Drug by Application
  1. 5.1 Gabapentin Drug Market by Application
  2. 5.1.1 Postherpetic Neuralgia in Adults
  3. 5.1.2 Partial Onset Seizures
  4. 5.1.3 Others
  5. 5.2 Global Gabapentin Drug Market Size by Application
  6. 5.2.1 Global Gabapentin Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gabapentin Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gabapentin Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gabapentin Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gabapentin Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gabapentin Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gabapentin Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gabapentin Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Gabapentin Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Gabapentin Drug Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Gabapentin Drug Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Gabapentin Drug Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Zydus Pharmaceuticals
  26. 6.5.1 Zydus Pharmaceuticals Company Information
  27. 6.5.2 Zydus Pharmaceuticals Business Overview
  28. 6.5.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
  30. 6.5.5 Zydus Pharmaceuticals Recent Developments
  31. 6.6 Tris Pharma
  32. 6.6.1 Tris Pharma Company Information
  33. 6.6.2 Tris Pharma Business Overview
  34. 6.6.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tris Pharma Gabapentin Drug Product Portfolio
  36. 6.6.5 Tris Pharma Recent Developments
  37. 6.7 Taro
  38. 6.7.1 Taro Company Information
  39. 6.7.2 Taro Business Overview
  40. 6.7.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Taro Gabapentin Drug Product Portfolio
  42. 6.7.5 Taro Recent Developments
  43. 6.8 Sciegen Pharmaceuticals
  44. 6.8.1 Sciegen Pharmaceuticals Company Information
  45. 6.8.2 Sciegen Pharmaceuticals Business Overview
  46. 6.8.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
  48. 6.8.5 Sciegen Pharmaceuticals Recent Developments
  49. 6.9 Marksans Pharma
  50. 6.9.1 Marksans Pharma Company Information
  51. 6.9.2 Marksans Pharma Business Overview
  52. 6.9.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Marksans Pharma Gabapentin Drug Product Portfolio
  54. 6.9.5 Marksans Pharma Recent Developments
  55. 6.10 Lupin Limited
  56. 6.10.1 Lupin Limited Company Information
  57. 6.10.2 Lupin Limited Business Overview
  58. 6.10.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lupin Limited Gabapentin Drug Product Portfolio
  60. 6.10.5 Lupin Limited Recent Developments
  61. 6.11 Jiangsu Hengrui Medicine
  62. 6.11.1 Jiangsu Hengrui Medicine Company Information
  63. 6.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 6.11.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
  66. 6.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 6.12 InvaGen Pharmaceuticals
  68. 6.12.1 InvaGen Pharmaceuticals Company Information
  69. 6.12.2 InvaGen Pharmaceuticals Business Overview
  70. 6.12.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
  72. 6.12.5 InvaGen Pharmaceuticals Recent Developments
  73. 6.13 Hi-Tech Pharmaceuticals
  74. 6.13.1 Hi-Tech Pharmaceuticals Company Information
  75. 6.13.2 Hi-Tech Pharmaceuticals Business Overview
  76. 6.13.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
  78. 6.13.5 Hi-Tech Pharmaceuticals Recent Developments
  79. 6.14 Glenmark
  80. 6.14.1 Glenmark Company Information
  81. 6.14.2 Glenmark Business Overview
  82. 6.14.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Glenmark Gabapentin Drug Product Portfolio
  84. 6.14.5 Glenmark Recent Developments
  85. 6.15 Epic Pharma
  86. 6.15.1 Epic Pharma Company Information
  87. 6.15.2 Epic Pharma Business Overview
  88. 6.15.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Epic Pharma Gabapentin Drug Product Portfolio
  90. 6.15.5 Epic Pharma Recent Developments
  91. 6.16 Depomed
  92. 6.16.1 Depomed Company Information
  93. 6.16.2 Depomed Business Overview
  94. 6.16.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Depomed Gabapentin Drug Product Portfolio
  96. 6.16.5 Depomed Recent Developments
  97. 6.17 CSPC Ouyi Pharmaceutical
  98. 6.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 6.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 6.17.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
  102. 6.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 6.18 Aurobindo Pharma
  104. 6.18.1 Aurobindo Pharma Company Information
  105. 6.18.2 Aurobindo Pharma Business Overview
  106. 6.18.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Aurobindo Pharma Gabapentin Drug Product Portfolio
  108. 6.18.5 Aurobindo Pharma Recent Developments
  109. 6.19 Apotex
  110. 6.19.1 Apotex Company Information
  111. 6.19.2 Apotex Business Overview
  112. 6.19.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Apotex Gabapentin Drug Product Portfolio
  114. 6.19.5 Apotex Recent Developments
  115. 6.20 Amneal Pharmaceuticals
  116. 6.20.1 Amneal Pharmaceuticals Company Information
  117. 6.20.2 Amneal Pharmaceuticals Business Overview
  118. 6.20.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
  120. 6.20.5 Amneal Pharmaceuticals Recent Developments
  121. 6.21 Alkem Laboratories
  122. 6.21.1 Alkem Laboratories Company Information
  123. 6.21.2 Alkem Laboratories Business Overview
  124. 6.21.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Alkem Laboratories Gabapentin Drug Product Portfolio
  126. 6.21.5 Alkem Laboratories Recent Developments
  127. 6.22 ACI HealthCare Limited
  128. 6.22.1 ACI HealthCare Limited Company Information
  129. 6.22.2 ACI HealthCare Limited Business Overview
  130. 6.22.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 ACI HealthCare Limited Gabapentin Drug Product Portfolio
  132. 6.22.5 ACI HealthCare Limited Recent Developments
  133. 6.23 Acella Pharmaceuticals
  134. 6.23.1 Acella Pharmaceuticals Company Information
  135. 6.23.2 Acella Pharmaceuticals Business Overview
  136. 6.23.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Acella Pharmaceuticals Gabapentin Drug Product Portfolio
  138. 6.23.5 Acella Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Gabapentin Drug Sales by Country
  2. 7.1.1 North America Gabapentin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gabapentin Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Gabapentin Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gabapentin Drug Market Size by Country
  6. 7.2.1 North America Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gabapentin Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Gabapentin Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gabapentin Drug Sales by Country
  2. 8.1.1 Europe Gabapentin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gabapentin Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Gabapentin Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gabapentin Drug Market Size by Country
  6. 8.2.1 Europe Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gabapentin Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gabapentin Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gabapentin Drug Sales by Country
  2. 9.1.1 Asia-Pacific Gabapentin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gabapentin Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gabapentin Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gabapentin Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gabapentin Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gabapentin Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gabapentin Drug Sales by Country
  2. 10.1.1 South America Gabapentin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gabapentin Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Gabapentin Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gabapentin Drug Market Size by Country
  6. 10.2.1 South America Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gabapentin Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Gabapentin Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gabapentin Drug Sales by Country
  2. 11.1.1 Middle East and Africa Gabapentin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gabapentin Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gabapentin Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gabapentin Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gabapentin Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gabapentin Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gabapentin Drug Value Chain Analysis
  2. 12.1.1 Gabapentin Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gabapentin Drug Production Mode & Process
  7. 12.2 Gabapentin Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gabapentin Drug Distributors
  10. 12.2.3 Gabapentin Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst